Naser Ahmadbeigi
Overview
Explore the profile of Naser Ahmadbeigi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
580
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ashraf H, Kosari F, Khorsand A, Muhammadnejad S, Mansouri V, Muhammadnejad A, et al.
Arch Iran Med
. 2025 Feb;
27(12):683-692.
PMID: 39891456
Background: Xenogeneic graft-versus-host disease (xGvHD) is an inevitable confounder of preclinical evaluation of adoptive immunotherapies on tumor-bearing immunodeficient mouse models. This study was designed to appraise the clinical and histopathological...
2.
Monzavi S, Muhammadnejad S, Mansouri V, Ashraf H, Ahmadbeigi N
Animal Model Exp Med
. 2024 Nov;
8(1):20-29.
PMID: 39601130
Human-derived tumor models are essential for preclinical development of new anticancer drug entities. Generating animal models bearing tumors of human origin, such as patient-derived or cell line-derived xenograft tumors, is...
3.
Molaei Z, Jabbarpour Z, Omidkhoda A, Ahmadbeigi N
Stem Cell Res Ther
. 2024 Jul;
15(1):233.
PMID: 39075609
Gene manipulation of hematopoietic stem cells (HSCs) using the CRISPR/Cas system as a potent genome editing tool holds immense promise for addressing hematologic disorders. An essential hurdle in advancing this...
4.
Moradi V, Khodabandehloo E, Alidadi M, Omidkhoda A, Ahmadbeigi N
Front Oncol
. 2024 Jun;
14:1388475.
PMID: 38912057
CAR-T cell therapy has shown remarkable promise in treating B-cell malignancies, which has sparked optimism about its potential to treat other types of cancer as well. Nevertheless, the Expectations of...
5.
Soufizadeh P, Mansouri V, Ahmadbeigi N
Lab Anim Res
. 2024 Apr;
40(1):17.
PMID: 38649954
Scientific progress heavily relies on rigorous research, adherence to scientific standards, and transparent reporting. Animal models play a crucial role in advancing biomedical research, especially in the field of gene...
6.
Rayati M, Mansouri V, Ahmadbeigi N
Heliyon
. 2024 Mar;
10(5):e27087.
PMID: 38439834
Glioblastoma multiforme (GBM) is one of the most lethal cancers with a poor prognosis. Over the past century since its initial discovery and medical description, the development of effective treatments...
7.
Moradi V, Omidkhoda A, Ahmadbeigi N
Biomed Pharmacother
. 2023 Nov;
169:115888.
PMID: 37979380
The advent of chimeric antigen receptor T cells (CAR-T cells) has made a tremendous revolution in the era of cancer immunotherapy, so that since 2017 eight CAR-T cell products have...
8.
Sahlolbei M, Azangou-Khyavy M, Khanali J, Khorsand B, Shiralipour A, Ahmadbeigi N, et al.
Heliyon
. 2023 Oct;
9(9):e19763.
PMID: 37809446
Background: Recent evidence suggests that B cells and autoantibodies have a substantial role in the pathogenesis of Multiple sclerosis. T cells could be engineered to express chimeric autoantibody receptors (CAARs),...
9.
Monzavi S, Hamidieh A, Vasei M, Ai J, Ahmadbeigi N, Arshadi H, et al.
Bioimpacts
. 2023 Sep;
13(5):415-424.
PMID: 37736339
Introduction: T cells that recognize WT1 peptides have been shown to efficiently eliminate WT1-expressing tumor cells. This study was designed to investigate the feasibility of isolating WT1-reactive T cells from...
10.
Jabbarpour Z, Aghayan S, Moradzadeh K, Ghaffari S, Ahmadbeigi N
BMC Immunol
. 2023 Sep;
24(1):28.
PMID: 37658313
Background: Cytokine-induced killer (CIK) cells have shown promising results in adoptive immunotherapy. However, serum may play a determining role in the large-scale expansion of these cells for clinical applications. According...